Delphi Panel Consensus Regarding Current Clinical Practice Management Options for Demodex blepharitis

References

• Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf. 2009;7(2 Suppl):S1–S14. doi:10.1016/s1542-0124(12)70620-1
   PubMed Web of Science ®Google Scholar
• Amescua G, Akpek EK, Farid M, et al. Blepharitis preferred practice pattern®. Ophthalmology. 2019;126(1):P56–P93. doi:10.1016/j.ophtha.2018.10.019
   PubMed Web of Science ®Google Scholar
• Arrúa M, Samudio M, Fariña N, et al. Comparative study of the efficacy of different treatment options in patients with chronic blepharitis. Arch Soc Esp Oftalmol. 2015;90(3):112–118. doi:10.1016/j.oftal.2013.09.003
   PubMedGoogle Scholar
• Lee SH, Chun YS, Kim JH, Kim ES, Kim JC. The relationship between demodex and ocular discomfort. Invest Ophthalmol Vis Sci. 2010;51(6):2906–2911. doi:10.1167/iovs.09-4850
   PubMed Web of Science ®Google Scholar
• Biernat MM, Rusiecka-Ziółkowska J, Piątkowska E, Helemejko I, Biernat P, Gościniak G. Occurrence of Demodex species in patients with blepharitis and in healthy individuals: a 10-year observational study. Jpn J Ophthalmol. 2018;62(6):628–633. doi:10.1007/s10384-018-0624-3
   PubMed Web of Science ®Google Scholar
• Kabataş N, Doğan AŞ, Kabataş EU, Acar M, Biçer T, Gürdal C. The effect of demodex infestation on blepharitis and the ocular symptoms. Eye Contact Lens. 2017;43(1):64–67. doi:10.1097/ICL.0000000000000234
   PubMed Web of Science ®Google Scholar
• Wesolowska M, Knysz B, Reich A, et al. Prevalence of Demodex spp. in eyelash follicles in different populations. Arch Med Sci. 2014;10(2):319–324. doi:10.5114/aoms.2014.42585
   PubMed Web of Science ®Google Scholar
• Teo A, Rosenberg E, Jacobson A. Prevalence of demodex colonization in patients presenting to an outpatient clinic. Invest Ophthalmol Vis Sci. 2021;62(8):1236.
   Web of Science ®Google Scholar
• Sadri E, Yeu E, Trattler W, Holdbrook M, Baba S. The prevalence of collarettes and Demodex blepharitis in ophthalmology and optometry practices (Titan study). Poster presented at: American Society of Cataract and Refractive Surgery (ASCRS); 2021; Las Vegas, NV. Available from: https://ascrsvirtualmeeting.ascrs.org/-/media/files/2021-papers/sps-107/75009-The-prevalence-of-collarettes-and-demodex-blepharitis-in-ophthalmology-and-optometry-practices.pdf.
   Google Scholar
• Liu J, Sheha H, Tseng SCG. Pathogenic role of Demodex mites in blepharitis. Curr Opin Allergy Clin Immunol. 2010;10(5):505–510. doi:10.1097/ACI.0b013e32833df9f4
   PubMed Web of Science ®Google Scholar
• Desch C, Nutting WB. Demodex folliculorum (Simon) and D. brevis akbulatova of man: redescription and reevaluation. J Parasitol. 1972;58(1):169–177. doi:10.2307/3278267
   PubMed Web of Science ®Google Scholar
• Nicholls SG, Oakley CL, Tan A, Vote BJ. Demodex species in human ocular disease: new clinicopathological aspects. Int Ophthalmol. 2017;37(1):303–312. doi:10.1007/s10792-016-0249-9
   PubMed Web of Science ®Google Scholar
• Kim JH, Chun YS, Kim JC. Clinical and immunological responses in ocular demodecosis. J Korean Med Sci. 2011;26(9):1231–1237. doi:10.3346/jkms.2011.26.9.1231
   PubMed Web of Science ®Google Scholar
• Zhang AC, Muntz A, Wang MTM, Craig JP, Downie LE. Ocular Demodex: a systematic review of the clinical literature. Ophthalm Physiol Opt. 2020;40(4):389–432. doi:10.1111/opo.12691
   PubMed Web of Science ®Google Scholar
• Coston TO. Demodex folliculorum blepharitis. Trans Am Ophthalmol Soc. 1967;65:361–392.
   PubMedGoogle Scholar
• Trattler W, Karpecki P, Rapoport Y, et al. The prevalence of demodex blepharitis in US eye care clinic patients as determined by collarettes: a pathognomonic sign. Clin Ophthalmol. 2022;16:1153–1164. doi:10.2147/OPTH.S354692
   PubMed Web of Science ®Google Scholar
• Fromstein SR, Harthan JS, Patel J, Opitz DL. Demodex blepharitis: clinical perspectives. Clin Optom. 2018;10:57–63. doi:10.2147/OPTO.S142708
   PubMed Web of Science ®Google Scholar
• Rabensteiner DF, Aminfar H, Boldin I, et al. Demodex mite infestation and its associations with tear film and ocular surface parameters in patients with ocular discomfort. Am J Ophthalmol. 2019;204:7–12. doi:10.1016/j.ajo.2019.03.007
   PubMed Web of Science ®Google Scholar
• Dalkey NC. The Delphi method: an Experimental Study of Group Opinion. RAND Corporation; 1969. Available from: https://www.rand.org/pubs/research_memoranda/RM5888.html. Accessed November 17, 2022.
   Google Scholar
• Santos MS, Alves MR, Freitas D, et al. Ocular allergy Latin American consensus. Arq Bras Oftalmol. 2011;74(6):452–456. doi:10.1590/s0004-27492011000600016
   PubMed Web of Science ®Google Scholar
• Ma Quintana J, Escobar A, Bilbao A. Explicit criteria for prioritization of cataract surgery. BMC Health Serv Res. 2006;6:24. doi:10.1186/1472-6963-6-24
   PubMed Web of Science ®Google Scholar
• Buchan JC, Dean WH, Foster A, Burton MJ. What are the priorities for improving cataract surgical outcomes in Africa? Results of a Delphi exercise. Int Ophthalmol. 2018;38(4):1409–1414. doi:10.1007/s10792-017-0599-y
   PubMed Web of Science ®Google Scholar
• Douglas RS, Tsirbas A, Gordon M, et al. Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique. Arch Ophthalmol. 2009;127(9):1155–1160. doi:10.1001/archophthalmol.2009.232
   PubMedGoogle Scholar
• Ferris FL, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120(4):844–851. doi:10.1016/j.ophtha.2012.10.036
   PubMed Web of Science ®Google Scholar
• Lee PP, Sultan MB, Grunden JW, Cioffi GA. Assessing the importance of IOP variables in glaucoma using a modified delphi process. J Glaucoma. 2010;19(5):281–287. doi:10.1097/IJG.0b013e3181b4ca8d
   PubMed Web of Science ®Google Scholar
• Lakhani BK, Giannouladis K, Leighton P, King AJ. Seeking a practical definition of stable glaucoma: a Delphi consensus survey of UK glaucoma consultants. Eye. 2020;34(2):335–343. doi:10.1038/s41433-019-0540-x
   PubMed Web of Science ®Google Scholar
• Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008
   PubMed Web of Science ®Google Scholar
• Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25(8):900–907. doi:10.1097/01.ico.0000214802.40313.fa
   PubMed Web of Science ®Google Scholar
• Tallouzi MO, Mathers JM, Moore DJ, et al. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis. Trials. 2017;18(1):576. doi:10.1186/s13063-017-2294-8
   PubMed Web of Science ®Google Scholar
• Thompson DA, Ali RR, Banin E, et al. Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano Symposium. Invest Ophthalmol Vis Sci. 2015;56(2):918–931. doi:10.1167/iovs.14-16049
   PubMed Web of Science ®Google Scholar
• Sodi A, Banfi S, Testa F, et al. RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy. Orphanet J Rare Dis. 2021;16(1):257. doi:10.1186/s13023-021-01868-4
   PubMed Web of Science ®Google Scholar
• Dana R, Farid M, Gupta PK, et al. Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy. BMC Ophthalmol. 2021;21(1):327. doi:10.1186/s12886-021-02092-1
   PubMed Web of Science ®Google Scholar
• Gomes JAP, Tan D, Rapuano CJ, et al. Global consensus on keratoconus and ectatic diseases. Cornea. 2015;34(4):359–369. doi:10.1097/ICO.0000000000000408
   PubMed Web of Science ®Google Scholar
• Ayres BD, Donnenfeld E, Farid M, et al. Clinical diagnosis and management of demodex blepharitis: the demodex expert panel of treatment and eyelid health (DEPTH). Eye. In Press 2023.
   PubMed Web of Science ®Google Scholar
• Shah PP, Stein RL, Perry HD. Update on the management of demodex blepharitis. Cornea. 2022;41(8):934–939. doi:10.1097/ICO.0000000000002911
   PubMed Web of Science ®Google Scholar
• Gonzalez-Salinas R, Yeu E, Holdbrook M, et al. Collarette elimination and demodex mite eradication with topical lotilaner ophthalmic solution, 0.25. J Ocul Pharmacol Ther. 2021;37(8):479–484. doi:10.1089/jop.2021.0011
   PubMed Web of Science ®Google Scholar
• Luo KS, Xie A, Yang JJ, Shen EP. Critical value of Demodex count per lash for symptomatic and clinical improvement of Demodex blepharitis. Eye. 2022;36(3):663–665. doi:10.1038/s41433-021-01442-z
   PubMed Web of Science ®Google Scholar
• Eubank BH, Mohtadi NG, Lafave MR, et al. Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology. BMC Med Res Methodol. 2016;16:56. doi:10.1186/s12874-016-0165-8
   PubMed Web of Science ®Google Scholar
• Niederberger M, Spranger J. Delphi technique in health sciences: a map. Front Public Health. 2020;8:457. doi:10.3389/fpubh.2020.00457
   PubMed Web of Science ®Google Scholar
• Fletcher AJ, Marchildon GP. Using the delphi method for qualitative, participatory action research in health leadership. Int J Qual Methods. 2014;13(1):1–8. doi:10.1177/160940691401300101
   Google Scholar
• Hsu CC, Sandford B. The delphi technique: making sense of consensus. Pract Assess Res Eval. 2019;12(1). doi:10.7275/pdz9-th90
   Google Scholar
• Khodyakov D, Chen C. Response changes in Delphi processes: why is it important to provide high-quality feedback to Delphi participants? J Clin Epidemiol. 2020;125:160–161. doi:10.1016/j.jclinepi.2020.04.029
   PubMed Web of Science ®Google Scholar
• Gonzalez-Salinas R, Yeu E, Holdbrook M, et al. Safety and efficacy of topical lotilaner ophthalmic solution 0.25% for the treatment of demodex blepharitis: a pilot study. J Ophthalmol. 2021;2021:3862684. doi:10.1155/2021/3862684
   PubMed Web of Science ®Google Scholar
• Eberhardt M, Rammohan G. Blepharitis. StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459305/. Accessed November 17, 2022.
   Google Scholar
• Kongsved SM, Basnov M, Holm-Christensen K, Hjollund NH. Response rate and completeness of questionnaires: a randomized study of Internet versus paper-and-pencil versions. J Med Internet Res. 2007;9(3):e25. doi:10.2196/jmir.9.3.e25
   PubMed Web of Science ®Google Scholar
• Brown B, Cochran SW, Dalkey NC. The DELPHI method, II: structure of experiments. RAND Corporation; 1969. Available from: https://www.rand.org/pubs/research_memoranda/RM5957.html. Accessed November 17, 2022.
   Google Scholar
• Chen D, Wang J, Sullivan DA, Kam WR, Liu Y. Effects of terpinen-4-ol on meibomian gland epithelial cells in vitro. Cornea. 2020;39(12):1541–1546. doi:10.1097/ICO.0000000000002506
   PubMed Web of Science ®Google Scholar
• Hirsch-Hoffmann S, Kaufmann C, Bänninger PB, Thiel MA. Treatment options for demodex blepharitis: patient choice and efficacy. Klin Monbl Augenheilkd. 2015;232(4):384–387. doi:10.1055/s-0035-1545780
   PubMed Web of Science ®Google Scholar
• Martínez-Pulgarín DF, Ávila MY, Rodríguez-Morales AJ. Interventions for Demodex blepharitis and their effectiveness: a systematic review and meta-analysis. Cont Lens Anterior Eye. 2021;44(6):101453. doi:10.1016/j.clae.2021.101453
   PubMed Web of Science ®Google Scholar
• Gonzalez-Salinas R, Karpecki P, Yeu E, et al. Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: a randomized, controlled, double-masked clinical trial. Cont Lens Anterior Eye. 2022;45(4):101492. doi:10.1016/j.clae.2021.101492
   PubMed Web of Science ®Google Scholar
• Cheng AMS, Sheha H, Tseng SCG. Recent advances on ocular Demodex infestation. Curr Opin Ophthalmol. 2015;26(4):295–300. doi:10.1097/ICU.0000000000000168
   PubMed Web of Science ®Google Scholar
• Rather PA, Hassan I. Human demodex mite: the versatile mite of dermatological importance. Indian J Dermatol. 2014;59(1):60–66. doi:10.4103/0019-5154.123498
   PubMed Web of Science ®Google Scholar
• Yeu E, Wirta DL, Karpecki P, Baba SN, Holdbrook M; Saturn I Study Group. Lotilaner ophthalmic solution, 0.25%, for the treatment of demodex blepharitis: results of a prospective, randomized, vehicle-controlled, double-masked, pivotal trial (Saturn-1). Cornea. 2022. doi:10.1097/ICO.0000000000003097
   PubMed Web of Science ®Google Scholar